VX IN THE NEWS
Read all about it and stay up to date with the latest developments in medical research and breakthrough science & technology
PRESS RELEASES
FLAIR PRESS RELEASE – ViiV Healthcare reports positive 48-week results
FDA APPROVAL OF ASTHMA INDICATION FOR DUPIXENT® (DUPILUMAB)